rna
interfer
rnai
conserv
gene
regulatori
mechan
employ
eukaryot
key
compon
innat
immun
respons
virus
retrotransposon
viral
infect
rnase
iiityp
endonucleas
dicer
cleav
viral
doublestrand
rna
small
interf
rna
sirna
nucleotid
length
help
load
rnainduc
silenc
complex
risc
guid
cleavag
complementari
viral
rna
countermeasur
mani
virus
evolv
viral
rna
silenc
suppressor
rss
protein
tightli
presum
quantit
bind
sirna
thwart
rnaimedi
degrad
viral
rss
protein
also
act
across
kingdom
potenti
immunosuppressor
gene
therapeut
applic
report
fluoresc
quench
electrophoret
mobil
shift
assay
probe
sirna
bind
dimer
rss
carnat
italian
ringspot
viru
cirv
well
human
dicer
risc
assembl
complex
find
sirna
interact
readili
revers
character
rapid
bind
mark
dissoci
k
also
observ
effici
compet
recombin
dicer
inhibit
format
riscrel
assembl
complex
found
human
cell
extract
comput
model
base
result
provid
evid
transient
format
ternari
complex
sirna
human
dicer
expand
model
rna
silenc
indic
multipleturnov
revers
bind
sirna
potenti
effici
suppressor
protein
predict
model
expect
applic
dose
silenc
suppressor
viral
gene
therapi
keyword
fluoresc
quench
rna
interfer
system
biolog
model
viral
silenc
suppressor
protein
rawl
et
al
past
decad
rna
interfer
rnai
becom
recogn
benchmark
laboratori
potenti
clinic
tool
control
gene
express
well
highli
conserv
eukaryot
immun
respons
viral
pathogen
transposon
viral
infect
plant
invertebr
cell
known
activ
rnai
viral
rna
specif
recogn
cytoplasm
rnase
iiityp
endonucleas
dicer
degrad
rnainduc
silenc
complex
risc
dicer
cleav
expos
stretch
doublestrand
rna
small
interf
rna
sirna
nucleotid
length
depend
speci
dicer
deliv
doublestrand
sirna
via
riscload
complex
risc
passeng
strand
duplex
cleav
releas
guid
strand
retain
guid
specif
cleavag
complementari
viral
rna
genom
transcript
dicer
thu
thought
play
critic
dual
role
rnai
gener
virusspecif
sirna
duplex
assembl
necessari
protein
compon
activ
risc
mammalian
includ
human
cell
artifici
sirna
shown
confer
antivir
immun
recent
evid
emerg
suggest
small
rna
includ
sirna
also
directli
gener
infect
virus
subvert
host
rnai
respons
mani
virus
evolv
small
protein
act
rna
silenc
suppressor
rsss
one
best
character
rsss
exemplifi
plant
pathogen
carnat
italian
ringspot
viru
cirv
encod
kda
protein
term
import
pathogen
factor
highli
conserv
among
tombusvirus
crystal
structur
recent
molecular
dynam
simul
show
homodim
bind
singl
sirna
duplex
posit
charg
surfac
cleft
fig
pair
tryptophan
residu
stack
termin
base
pair
establish
sequenceindepend
caliperlik
size
select
sirna
duplex
base
pair
long
sequestr
bind
dicergener
sirna
observ
correl
reduc
viral
rna
degrad
system
symptom
spread
sustain
viral
phenotyp
infect
previou
electrophoret
mobil
shift
assay
emsa
suggest
affin
dimer
sirna
high
appar
equilibrium
dissoci
constant
k
p
nm
tight
bind
consist
wide
accept
sequestr
model
wherein
dimer
nearquantit
bind
sirna
duplex
suppress
rnai
bind
doublestrand
rna
consid
common
rss
mechan
yet
measur
sirna
bind
dissoci
kinet
better
understand
sequestr
report
date
rss
protein
develop
solutionbas
fluoresc
quench
assay
observ
sirna
sp
bind
readili
revers
rapid
bind
rate
constant
also
dissoci
rate
constant
k
markedli
faster
slowreleas
nucleic
acid
bind
protein
result
consist
within
error
high
appar
affin
measur
emsa
yet
expand
sequestr
model
bind
complet
irrevers
would
requir
viru
gener
suffici
quantiti
dimer
quantit
bind
small
rna
produc
enzymat
either
dicer
cleavag
amplif
effect
plant
cell
rnadepend
rna
polymeras
contrast
facil
revers
sp
complex
format
open
possibl
multipleturnov
may
potenti
efficaci
rss
particular
disrupt
sirna
dicer
sd
interact
via
multipleturnov
would
potent
interfer
role
dicer
obligatori
risc
assembl
factor
consist
mechan
action
observ
effici
competit
sirna
bind
activ
recombin
human
dicer
absenc
known
risc
compon
well
promin
disrupt
risc
assembl
complex
observ
human
hela
cell
extract
contain
three
core
riscload
complex
compon
dicer
trbp
mathemat
model
demonstr
dicer
competit
data
accur
reproduc
assum
format
transient
ternari
complex
sirna
dicer
sdp
taken
togeth
multipleturnov
catch
releas
mechan
emerg
wherein
repeatedli
promot
dissoci
sd
complex
effici
suppress
dicermedi
risc
assembl
fluoresc
assay
observ
sirna
complex
format
sitespecif
label
antisens
guid
strand
establish
luciferasetarget
sirna
duplex
either
fluorescein
tetramethylrhodamin
fluoresc
quench
probe
posit
expect
interfer
bind
fig
found
tetramethylrhodamin
label
effici
quench
upon
addit
fig
addit
buffer
protein
recombin
dicer
caus
quench
supplementari
fig
observ
robust
quench
signal
upon
addit
proceed
label
fluorophor
togeth
allow
us
monitor
normal
tetramethylrhodamin
fluorescein
tf
fluoresc
ratio
insensit
dilut
effect
perturb
otherwis
rel
fluoresc
signal
next
test
emsa
bind
doublylabel
sirna
unlabel
sirna
detect
interfer
fluorophor
k
p
nm
case
consist
earlier
emsa
studi
fig
timeresolv
fluoresc
reson
energi
transfer
trfret
two
fluorophor
reveal
small
increas
fluorophor
distanc
distribut
upon
addit
mean
distanc
increas
fig
indic
format
sp
complex
lead
minor
deform
sirna
duplex
expect
xray
crystallographi
conclud
doublylabel
sirna
duplex
suitabl
report
format
sirna
interact
solut
addit
increas
excess
concentr
doublylabel
sirna
led
increas
pseudofirst
order
rate
constant
tetramethylrhodamin
quench
monitor
tf
ratio
yield
bimolecular
bind
rate
constant
k
fig
b
next
dissoci
preform
sp
complex
monitor
upon
addit
larg
excess
unlabel
sirna
chase
yield
dissoci
rate
constant
k
fig
supplementari
fig
togeth
rapid
k
solutionbas
dissoci
equilibrium
constant
k
k
k
p
sol
nm
obtain
within
emsa
predict
valu
nm
attest
highaffin
yet
also
notabl
revers
sirna
bind
mode
critic
dual
role
dicer
rnai
enzym
produc
sirna
risc
assembl
factor
suggest
sirna
dicer
sd
interact
particularli
vulner
step
rna
silenc
previou
studi
embryo
extract
fruitfli
drosophila
shown
suppress
rna
silenc
compet
complex
determin
whether
also
compet
human
dicer
sirna
employ
emsa
use
radiolabel
sirna
duplex
activ
recombin
human
dicer
prepar
devoid
known
risc
protein
supplementari
fig
avail
rel
crude
purif
heterolog
overexpress
dicer
genlanti
see
materi
method
measur
appar
equilibrium
dissoci
constant
human
sd
complex
k
nm
fig
supplementari
fig
presenc
low
concentr
nm
equival
k
p
sp
complex
weaken
interact
nm
fig
supplementari
fig
presenc
satur
concentr
nm
weaken
interact
still
estim
lower
limit
fig
supplementari
fig
find
led
us
hypothes
function
inhibit
rnai
human
interrupt
sd
complex
dicer
hand
sirna
risc
reciproc
competit
experi
show
presenc
even
satur
concentr
nm
dicer
lower
appar
affin
sirna
margin
nm
nm
fig
supplementari
fig
e
support
hypothesi
strong
competit
sd
complex
import
mode
action
inhibit
rnai
human
cell
previou
studi
drosophila
extract
shown
inhibit
risc
assembl
disrupt
preassembl
risc
lesser
extent
result
disrupt
complex
recombin
human
dicer
sirna
suggest
may
also
effect
suppress
risc
assembl
mammal
test
hypothesi
probe
effect
format
human
riscrel
complex
use
modifi
vitro
risc
assembl
assay
specif
incub
radiolabel
sirna
duplex
vv
cytosol
hela
cell
extract
show
contain
three
core
riscload
complex
compon
dicer
trbp
supplementari
fig
analyz
product
emsa
autoradiographi
fig
b
three
distinct
sirnacontain
complex
observ
correspond
previous
observ
includ
slowlymigr
complex
thought
contain
dicer
well
two
faster
migrat
band
term
fig
normal
fraction
complex
decreas
period
wherea
complex
fraction
increas
estim
rate
constant
respect
fig
test
presenc
dicer
perform
supershift
assay
antidic
polyclon
antibodi
found
complex
specif
supershift
antibodi
fig
similarli
dicer
detect
western
blot
complex
supplementari
fig
notabl
ad
increas
concentr
cell
extract
prior
sirna
addit
increasingli
impair
format
three
sirnacontain
complex
concomit
accumul
compet
sp
complex
fig
e
ad
risc
assembl
assay
h
preincub
sirna
format
particularli
dicercontain
complex
inhibit
lesser
extent
fig
g
similar
result
obtain
higher
hela
cell
extract
concentr
temperatur
supplementari
fig
mechan
competit
human
dicer
determin
mathemat
model
two
possibl
mode
competit
twoproteinsinglesubstr
system
first
competit
may
occur
dissoci
bind
mode
higher
affin
protein
shift
rel
equilibrium
system
bind
avail
substrat
dissoci
competitor
thu
establish
new
equilibrium
posit
fig
case
dicer
sirna
preassoci
dicer
onset
due
cleavag
longer
rna
make
dissoci
bind
rel
fast
spontan
dissoci
dicer
rapid
second
competit
may
occur
format
ternari
complex
intermedi
involv
sirna
dicer
fig
use
previous
determin
gelbas
appar
dissoci
equilibrium
constant
k
p
nm
dicer
k
nm
discrimin
two
possibl
mode
competit
calcul
result
expect
sirna
dicer
sirna
complex
fraction
compar
experi
given
set
equilibrium
condit
assumpt
dissoci
bind
mechan
show
poor
correl
experi
evid
fact
chang
upon
ad
dicer
consist
overestim
fig
chang
upon
ad
consist
underestim
fig
poor
correl
suggest
ternari
complex
format
need
explain
observ
effici
disrupt
sirna
dicer
complex
presenc
inclus
ternari
complex
format
mechan
creat
thermodynam
cycl
requir
ratio
k
k
sp
equal
k
p
k
sd
rearrang
use
valu
k
k
p
find
k
sp
k
sd
k
k
p
therefor
k
sp
k
sd
result
suggest
dissoci
ternari
complex
binari
sirna
complex
like
dissoci
sirna
dicer
complex
indic
sirna
inde
effect
shuttl
toward
bound
state
assum
transient
format
ternari
sirna
dicer
complex
result
model
correl
well
experi
explain
weak
effect
dicer
addit
sirna
complex
larg
effect
addit
sirna
dicer
complex
fig
b
similar
result
observ
place
context
rnai
pathway
follow
interpret
unifi
result
expand
previous
publish
simplifi
steadyst
kinet
model
encapsul
key
featur
rnai
pathway
includ
rna
cleavag
dicer
sirna
incorpor
risc
result
riscmedi
rna
degrad
includ
experiment
observ
competit
sirna
dicer
interact
revers
interact
sirna
model
possibl
multipleturnov
catch
releas
mechan
emerg
wherein
effect
recycl
success
compet
dicer
dissoci
sirna
fig
next
sought
establish
impact
mechan
abil
suppress
rnai
detail
model
analysi
see
supplementari
inform
model
suggest
intracellular
steadyst
load
viral
protein
thu
viral
viabil
specifi
three
global
paramet
fig
effici
dicer
rnai
specif
host
cell
type
v
three
global
paramet
compos
detail
mechanist
paramet
supplementari
tabl
supplementari
inform
case
irrevers
bind
sirna
singl
turnov
rel
enhanc
viral
protein
load
presenc
absenc
irr
describ
lead
neglig
depend
suppress
effici
v
fig
use
realist
paramet
space
tabl
materi
method
case
revers
form
sp
complex
observ
experiment
work
two
addit
model
paramet
come
play
fig
fraction
sirna
success
reenter
rnai
pathway
releas
n
fraction
total
bound
sirna
valu
n
close
zero
lead
recycl
protein
without
reincorpor
releas
sirna
risc
wherea
valu
n
close
uniti
effect
reduc
free
concentr
without
chang
fate
bound
sirna
eventu
guid
risc
previou
studi
shown
dicer
substrat
subnanomolar
concentr
effect
gene
knockdown
matur
sirna
suggest
low
probabl
n
reincorpor
free
sirna
rnai
pathway
especi
low
sirna
concentr
expect
earli
stage
viral
infect
previou
experiment
studi
drosophila
embryo
lysat
shown
effect
prevent
low
nanomolar
concentr
sirna
incorpor
risc
less
effect
disrupt
matur
risc
featur
also
evid
data
compar
fig
g
suggest
inde
earli
stage
viral
infect
n
small
may
effect
rnai
suppress
rel
enhanc
viral
protein
load
presenc
absenc
revers
bind
model
rev
describ
k
dissoci
constant
sp
complex
k
catd
cleavag
rate
constant
dicer
model
predict
hyperbol
depend
rev
effici
v
littl
depend
fig
estim
experiment
data
fig
b
rang
revers
sirna
bind
thu
found
enhanc
viral
protein
product
observ
irrevers
bind
model
fig
notabl
even
valu
n
diminish
effect
much
due
closetolinear
decreas
rev
toward
uniti
increas
n
toward
uniti
data
shown
small
positivesens
singlestrand
rna
genom
tombusvirus
encod
rss
thought
critic
symptom
spread
cytotox
class
plant
pathogen
abil
bind
thu
sequest
dicergener
sirna
propos
use
therapeut
research
applic
includ
mammalian
gene
therapi
vaccin
product
human
retrovir
protein
homolog
motiv
studi
outsid
natur
host
environ
across
kingdom
boundari
investig
bind
gener
sirna
cirv
fluoresc
quench
assay
combin
radioact
emsa
notic
dissoci
sirna
k
counterbalanc
fast
associ
yield
solut
base
dissoci
equilibrium
constant
k
nm
fig
within
high
affin
previous
deduc
emsa
dissoci
sirna
nearli
three
ordersofmagnitud
faster
observ
mani
highaffin
nucleic
acidprotein
complex
dissoci
rate
constant
order
strikingli
rate
equilibrium
constant
sirna
complex
resembl
protein
rev
interact
rev
respons
element
rre
rna
k
k
perhap
due
similarli
primarili
nonsequ
specif
bind
small
protein
partial
base
pair
rna
duplex
presenc
even
low
concentr
dramat
weaken
interact
recombin
human
dicer
sirna
product
depend
concentr
fig
absenc
detect
risc
compon
convers
presenc
satur
concentr
dicer
slightli
lower
affin
sirna
fig
support
hypothesi
strong
competit
sd
complex
import
mode
action
vivo
accordingli
assembl
assay
show
also
strongli
disrupt
riscrel
human
sirnaprotein
complex
observ
hela
cell
extract
show
contain
core
riscload
complex
compon
dicer
trbp
supplementari
fig
e
suggest
abl
disrupt
sd
complex
even
context
full
complement
risc
compon
fig
experiment
result
inform
mathemat
model
competit
dicer
sirna
well
steadyst
interact
sirna
dicer
risc
viral
rna
determin
minim
model
necessari
achiev
experiment
observ
level
competit
dicer
sirna
requir
postul
transient
ternari
complex
favor
dissoci
sirna
complex
free
dicer
fig
addit
expand
steadyst
kinet
model
predict
signific
enhanc
viral
protein
load
sirna
interact
assum
revers
observ
experiment
result
thu
invok
multipleturnov
catch
releas
mechan
wherein
unlik
releas
sirna
effect
recycl
success
compet
dicer
fig
notabl
dissoci
rate
constant
sirna
complex
lower
thu
closer
slowreleas
protein
would
effici
compet
dicer
sirna
also
less
effici
releas
sirna
achiev
multipleturnov
tempt
specul
evolut
way
yield
sirna
bind
properti
optim
rnai
suppress
mathemat
model
reli
assumpt
includ
experiment
deriv
estim
low
probabl
n
reincorpor
sirna
releas
rnai
pathway
depend
predict
rnai
suppress
rel
shallow
depend
n
n
predict
enhanc
suppress
experiment
observ
revers
sirna
interact
strikingli
estim
enhanc
rnai
suppress
revers
sirna
complex
format
similar
magnitud
typic
rnai
effect
microrna
express
cellular
gene
suggest
even
modest
chang
gene
express
level
predict
profound
biolog
consequ
case
likelihood
surviv
viru
host
sever
implic
struggl
viru
cellular
rnai
machineri
aris
work
first
gene
therapeut
applic
requir
effect
outsid
natur
host
environ
studi
protein
potenti
interact
partner
far
lack
observ
context
human
cellular
compon
find
evid
ternari
complex
format
sirna
human
dicer
experiment
data
suggest
observ
effici
competit
sirna
dicer
complex
fig
result
dicercontain
risc
assembl
complex
fig
target
particularli
critic
step
path
activ
risc
recent
reconstruct
negativelystain
electron
microscopi
imag
human
dicer
complex
depict
fistlik
shape
central
flat
surfac
thought
bind
sirna
architectur
along
known
bind
mode
rais
possibl
could
bind
opposit
face
sirna
ternari
complex
dicer
notabl
crystal
structur
sever
viral
suppressor
also
appear
bind
one
face
sirna
leav
opposit
face
open
potenti
accommod
protein
dicer
observ
format
supershift
band
indic
ternari
complex
emsa
sirna
human
dicer
fig
complex
may
simpli
shortliv
emsa
low
resolut
complex
detect
second
previous
propos
simpl
sequestr
model
would
requir
stoichiometr
concentr
rel
sirna
duplex
nativ
cirv
gener
dicer
well
small
duplex
rna
bound
includ
defect
interf
rna
sirna
amplif
product
gener
plant
cell
rnadepend
rna
polymeras
activ
perhap
mirna
duplex
independ
confirm
abil
bind
human
mirna
use
conserv
ubiquit
wellstudi
mirna
implic
tumor
suppress
remark
observ
bind
partial
mismatch
doublestrand
mirna
sirna
equal
affin
nm
nm
respect
supplementari
fig
similar
observ
recent
studi
use
affinitycaptur
approach
show
cirv
retain
high
affin
mirna
well
fluorophor
label
sirna
observ
underscor
may
face
larg
background
competitor
rna
target
sirna
substrat
although
specif
base
pair
pattern
plant
mirna
may
disfavor
bind
find
format
highaffin
sirna
complex
readili
revers
fig
still
interf
sirna
bind
dicer
riscrel
assembl
complex
vitro
fig
rais
possibl
substoichiometr
concentr
may
suffic
vivo
prevent
sirna
multipleturnov
assembl
risc
fashion
viru
could
keep
pace
amplifi
host
respons
system
rnai
selfdefens
plant
host
cirv
third
result
immedi
impact
understand
physicochem
properti
biolog
function
practic
consider
also
aris
work
futur
rnai
base
strategi
may
well
depend
abil
control
predict
rel
intracellular
express
level
risc
compon
potenti
therapeut
short
hairpin
rna
shrna
exampl
shown
vivo
effici
induc
gene
silenc
longterm
investig
found
caus
dosedepend
liver
injuri
ultim
death
adult
mice
sustain
high
level
caus
dysregul
microrna
increas
tumorigenesi
margin
dose
coexpress
could
help
amelior
toxic
effect
shrna
addit
cirv
rss
shown
aid
transfect
difficult
overexpress
alpha
adeno
lentivirus
use
gene
therapi
plant
base
vaccin
abil
suppress
intracellular
rnai
immun
respons
immunosuppress
effect
dose
rss
import
analog
use
immunosuppress
organ
transplant
surgeri
fact
observ
least
mirna
tightli
bind
caution
advers
development
effect
due
sequestr
essenti
cellular
rna
care
avoid
understand
model
relev
biophys
properti
rnai
process
presenc
rsss
advanc
thu
anticip
becom
critic
broader
safer
use
rnai
therapeut
human
diseas
control
purifi
protein
prepar
previous
describ
dimer
concentr
measur
bradford
assay
recombin
human
dicer
prepar
genlanti
use
baculoviru
system
commerci
avail
protocol
invitrogen
histag
dicer
purifi
ni
column
tag
remov
tev
proteas
cleavag
remov
contamin
factor
remain
bound
recombin
dicer
cytosol
hela
cell
extract
obtain
jena
bioscienc
integr
dicer
sampl
test
western
blot
analysi
supplementari
fig
addit
demonstr
biolog
activ
recombin
dicer
cleavag
assay
use
long
doublestrand
rna
substrat
supplementari
fig
estim
dicer
concentr
partial
purifi
prepar
deriv
bradford
assay
measur
total
protein
concentr
combin
puriti
quot
genlanti
verifi
coomassi
stain
denatur
sdspage
gel
supplementari
fig
estim
conserv
higher
rel
puriti
would
impli
even
higher
concentr
dicer
need
effici
compet
sirna
bind
rna
synthes
hhmi
biopolymerkeck
foundat
biotechnolog
resourc
laboratori
yale
univers
school
medicin
deprotect
purifi
previous
describ
sirna
sequenc
deriv
firefli
luciferas
gene
follow
sens
strand
acg
cgg
aau
acu
ucg
antisens
strand
aag
fluoresceindt
au
ucc
gcg
amino
ac
p
denot
fluoresceindt
amino
denot
phosphoramidit
name
glen
research
antisens
strand
also
synthes
one
modif
wherein
u
replac
modifi
dt
need
tetramethylrhodamin
coupl
amino
linker
rna
purifi
describ
mirna
sequenc
deriv
human
wildtyp
mirna
follow
antisens
strand
ggu
agu
agg
uug
uau
agu
sens
strand
uac
aau
cua
cug
ucu
uuc
standard
fluoresc
measur
perform
aminco
bowman
spectrofluoromet
thermo
scientif
sirna
duplex
form
mix
excess
nm
unlabel
sens
strand
nm
label
sens
strand
nearphysiolog
standard
buffer
mm
trisacet
ph
mm
kcl
mm
nacl
mm
mgcl
mm
dtt
vv
tween
heat
anneal
min
cool
room
temperatur
min
fluoresceintetramethylrhodamin
doublylabel
sirna
excit
nm
nm
slit
width
emiss
altern
detect
nm
fluorescein
f
nm
nm
slit
width
tetramethylrhodamin
calcul
f
ratio
f
singlylabel
sirna
exciteddetect
nm
respect
typic
experi
ad
nm
label
sirna
mix
manual
final
concentr
nm
unless
otherwis
indic
chase
experi
unmodifi
sirna
duplex
form
anneal
unlabel
composit
sens
antisens
rna
strand
ratio
standard
buffer
ad
final
concentr
satur
chase
ensur
triplic
trial
use
nm
nm
supplementari
fig
observ
fast
sp
complex
format
sirna
sampl
prepar
standard
buffer
final
concentr
nm
standard
buffer
ad
vari
least
final
excess
concentr
kintek
stoppedflow
spectrofluoromet
excit
nm
detect
emiss
nm
time
cours
fit
singleexponenti
increas
decreas
function
origin
originlab
describ
radioact
emsa
nonphosphoryl
antisens
strand
first
p
label
polynucleotid
kinas
pnk
patp
rna
concentr
nm
pnk
inactiv
heat
min
phosphoryl
complementari
strand
ad
molar
excess
reaction
slowli
cool
room
temperatur
anneal
two
strand
sirna
duplex
purifi
nondenatur
wv
polyacrylamid
gel
electrophoresi
duplex
sirna
cut
elut
overnight
mm
edta
ethanol
precipit
dissolv
rnasefre
water
scintil
count
done
beckman
multipurpos
scintil
counter
emsa
perform
describ
previous
nondenatur
wv
polyacrylamid
gel
tbe
mm
trisbor
mm
edta
run
v
h
dicer
vari
final
concentr
ad
radiolabel
sirna
duplex
cpm
pm
p
label
duplex
standard
buffer
incub
hr
next
nondenatur
load
buffer
glycerol
tbe
bromophenol
blue
xylen
cyanol
ad
sampl
load
well
emsa
gel
competit
experi
perform
preincub
pm
sirna
duplex
prepar
standard
buffer
either
nm
dicer
increas
concentr
nm
nm
increas
concentr
dicer
gel
chase
experi
done
standard
buffer
nm
dicer
respect
p
label
sirna
addit
nm
unlabel
sirna
chase
min
gel
wrap
plastic
wrap
expos
phosphor
screen
scan
storm
phosphorimag
quantifi
use
imag
quant
softwar
molecular
dynam
rel
fraction
f
relev
protein
complex
fit
follow
hyperbol
bind
isotherm
extract
satur
point
f
max
halftitr
point
k
app
observ
risc
assembl
complex
vv
cytosol
hela
cell
extract
incub
pm
sirna
duplex
prepar
final
volum
hela
buffer
vv
lysi
buffer
mm
hepe
ph
mm
potassium
acet
mm
magnesium
acet
mm
dtt
mgml
perabloc
sc
roch
supplement
vv
rnai
mix
mm
creatin
phosphat
mm
atp
mm
dtt
wv
creatin
kinas
vv
rna
guard
rnase
inhibitor
ge
bioscienc
h
unless
otherwis
specifi
competit
experi
ad
increas
concentr
hela
cell
extractsirna
mixtur
either
immedi
h
preincub
time
cours
stop
direct
load
onto
run
nondenatur
wv
polyacrylamid
gel
tbe
mm
trisbor
mm
edta
run
mwcm
comparison
previou
assay
vv
hela
cell
extract
incub
sirna
describ
h
analyz
emsa
yield
similar
result
supplementari
fig
vv
extract
prefer
work
due
better
ph
control
afford
lower
concentr
conserv
materi
antibodi
supershift
emsa
cytosol
hela
cell
extract
total
protein
preincub
antidic
rabbit
polyclon
antibodi
santa
cruz
biotechnolog
inc
unrel
control
antibodi
either
antidsr
rabbit
polyclon
antibodi
clontech
laboratori
inc
actin
mous
monoclon
antibodi
sigmaaldrich
inc
h
prior
risc
assembl
assay
final
volum
per
lane
nondenatur
wv
polyacrylamid
gel
electrophoresi
use
resolv
complex
describ
time
cours
titrat
curv
fit
timeresolv
donor
fluorescein
f
fluoresc
decay
collect
presenc
absenc
acceptor
tetramethylrhodamin
use
timecorrel
singlephoton
count
previous
describ
donor
decay
presenc
acceptor
model
weight
averag
decay
donoracceptor
distanc
ensembl
molecul
assum
threedimension
gaussian
distanc
distribut
distanc
f
denatur
western
blot
cytosol
hela
cell
extract
recombin
dicer
enzym
prepar
recombin
trbp
abcam
abnova
protein
run
nupag
novex
gradient
bistri
gel
presenc
molecular
weight
marker
ecl
plex
rainbow
marker
gel
electroblot
trisglycin
buffer
mm
tri
mm
glycin
vv
methanol
onto
polyvinyliden
fluorid
pvdf
membran
immobilonp
membran
millipor
min
use
biorad
transblot
sd
semidri
transfer
cell
per
manufactur
instruct
transfer
membran
probe
either
rabbit
antidic
santa
cruz
biotechnolog
mous
antitrbp
mous
abnova
follow
goat
goat
amersham
respect
probe
blot
supplementari
fig
e
visual
typhoon
variabl
mode
imag
ge
healthcar
life
scienc
nondenatur
western
blot
risc
assembl
complex
form
describ
reaction
scale
gel
soak
wv
sd
min
electroblot
trisglycin
transfer
buffer
mm
tri
mm
glycin
onto
pvdf
membran
immobilonp
membran
millipor
min
use
biorad
transblot
sd
semidri
transfer
cell
per
manufactur
instruct
transfer
protein
fix
membran
incub
vv
acet
acid
rins
deioniz
water
air
dri
membran
probe
rabbit
primari
antibodi
dicer
santa
cruz
biotechnolog
follow
goat
antirabbit
secondari
antibodi
conjug
horseradish
peroxidas
zyme
invitrogen
blot
develop
use
peroxideenhanc
solut
eclplu
detect
amersham
visual
typhoon
variabl
mode
imag
supplementari
fig
model
describ
schemat
fig
chang
viral
protein
express
level
monitor
steadyst
absenc
presenc
rss
chang
free
protein
time
depend
term
repres
natur
rate
product
r
x
r
r
dm
degrad
r
dp
extent
sirna
bind
k
sirna
p
sirna
complex
dissoci
k
sp
product
govern
transcript
rate
rx
messeng
rna
degrad
rate
r
dm
translat
rate
r
assum
reach
equilibrium
timescal
faster
repress
protein
degrad
firstord
rate
constant
r
dp
lead
amount
usabl
sirna
system
ie
fraction
abl
associ
risc
reduc
amount
sirna
bound
product
sirna
depend
catalyt
rate
constant
dicer
k
catd
sirna
degrad
first
order
rate
constant
r
ds
paramet
n
fraction
sirna
reenter
rnai
pathway
dissoci
yield
time
evolut
viral
protein
interest
serv
report
rnai
suppress
enhanc
describ
k
catr
catalyt
rate
constant
riscmedi
cleavag
mrna
addit
term
denomin
equat
quasisteadi
state
assumpt
use
previou
work
describ
risc
mediat
degrad
viral
messeng
rna
mrna
assum
activ
concentr
sirnaload
risc
approach
steadyst
valu
rate
constant
k
catr
buildup
sirnaload
risc
contribut
rate
degrad
viral
mrna
describ
concentr
risc
sirna
well
dissoci
constant
k
dr
protein
silenc
rnai
repres
steadyst
unitless
constant
equat
rescal
describ
marshal
solv
steadyst
yield
paramet
previous
describ
effici
rnai
pathway
rnai
settl
time
respect
paramet
v
fraction
sirnabound
rel
total
effici
effici
dicer
particular
cell
line
respect
level
viral
protein
steadyst
depend
mostli
exampl
absenc
rnai
ie
absenc
dicer
v
viral
protein
level
suppress
substitut
equat
equat
yield
two
solut
choos
biolog
relev
one
substitut
equat
yield
bind
assum
irrevers
ie
k
v
solv
absenc
ie
p
base
equat
v
reduc
fulli
suppress
protein
level
enhanc
viral
protein
product
due
either
irrevers
irr
revers
bind
rev
found
see
also
fig
refer
web
version
pubm
central
supplementari
materi
kinet
format
dissoci
sirna
complex
pseudofirst
order
kinet
bind
doublylabel
sirna
nm
excess
measur
tf
ratio
stoppedflow
mix
scatter
point
denot
raw
data
line
denot
singleexponenti
fit
extract
rate
constant
b
plot
observ
pseudofirst
rate
constant
panel
concentr
linear
fit
yield
indic
bimolecular
bind
rate
constant
k
c
fluoresc
detect
bind
doublylabel
sirna
nm
nm
complex
dissoci
upon
addit
unlabel
sirna
chase
singleexponenti
fit
red
line
yield
indic
dissoci
rate
constant
k
steadyst
kinet
model
action
rnai
suppress
schemat
expand
catch
releas
mathemat
model
v
describ
effici
dicer
rnai
cell
respect
n
fraction
sirna
success
reenter
rnai
pathway
releas
matur
human
risc
singl
strand
sirna
bound
may
may
contain
dicer
dash
outlin
b
enhanc
viral
protein
load
unsuppress
protein
level
assum
revers
irrevers
bind
rev
irr
respect
fraction
sirna
complex
free
increas
effici
v
increas
enhanc
level
viral
protein
due
revers
bind
therefor
fall
within
rang
grey
area
determin
rang
upper
bound
lower
bound
